SCHEMBL21101912

SCHEMBL21101912

CC(=O)Cc1cc(C(C)(C)F)cc(C(C)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.35
RXRA P19793 3/20 0.33
RXRB P28702 3/20 0.33
RXRG P48443 3/20 0.33
CYP2C19 P33261 3/20 0.32
USP2 O75604 2/20 0.32
CYP1A2 P05177 2/20 0.32
POLB P06746 1/20 0.32
IDO1 P14902 2/20 0.32
HPGD P15428 1/20 0.31
CYP2D6 P10635 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
CES2 O00748 1/20 0.31
GRIA2 P42262 1/20 0.30
GBA1 P04062 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21101918 0.94 TACR1 (0.37) TACR1RXRARXRBRXRGCYP2C19
SCHEMBL21101913 0.83 MEN1 (0.34) TACR1CYP2C19CYP1A2CYP2D6
SCHEMBL6492340 0.81 IDO1 (0.48) TACR1RXRARXRBRXRGCYP2C19
SCHEMBL21101768 0.80 RXRA (0.44) RXRARXRBRXRGCYP1A2POLB
SCHEMBL21101915 0.80 TACR1 (0.36) TACR1CYP2C19CYP1A2CYP2D6PSEN1
SCHEMBL4286759 0.79 RXRA (0.49) RXRARXRBRXRGCYP2C19USP2
SCHEMBL16560482 0.78 CA2 (0.39) TACR1CYP2C19CYP1A2
SCHEMBL21101909 0.77 CYP1A2 (0.50) CYP2C19CYP1A2IDO1
SCHEMBL21101910 0.76 POLB (0.46) RXRARXRBRXRGCYP2C19POLB
SCHEMBL12301741 0.71 TACR1 (0.40) TACR1RXRARXRBRXRGIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed